The Global Health Body Sounds Alert Over Acute Scarcity of Obesity Injections
Under 10% of people who could benefit from obesity jabs including Wegovy can access them, caution the World Health Organization as it releases its inaugural advice on the medications.
Given in excess of 1,000,000,000 people worldwide currently classified as obese, it is advocating for more widespread and fairer availability to this class of drugs.
Based on projections, more than two billion will be obese by 2030 unless action is taken.
"The new guidance affirms that excess weight is a long-term condition that can be managed with thorough and lifelong support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and supply-chain constraints are significant obstacles to broad access to the injections that can assist patients in reducing substantial body mass, says the body.
Skinny Jab Shortage
Even in the present best projected scenario, the manufacturing of these medications could only cover approximately 100 million people – under 10% of those who need them, according to the health organization.
The advice urges nations and manufacturers to increase access, by measures including patent sharing.
Exclusive production rights on semaglutide – the core ingredient of the drug Wegovy – is due to expire in a number of nations in 2026.
The Way Obesity Drugs Function
The injections replicate a natural hormone to delay gastric emptying, reduce hunger and increase the sense of being full so people eat less.
People commonly begin shedding pounds after several weeks of beginning the regular doses.
Evidence indicates people may regain a significant portion a year later of discontinuing the medication, as their typical appetite resume.
To be above a healthy weight raises your likelihood for developing medical conditions, including diabetes, cardiovascular issues, stroke, and some malignancies.
Obesity affects people in all nations and was linked to millions of fatalities worldwide in 2024, as per the health agency.
